These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30389594)

  • 1. Cardiac mitochondrial structure and function in tafazzin-knockdown mice.
    Kim J; Lee K; Fujioka H; Tandler B; Hoppel CL
    Mitochondrion; 2018 Nov; 43():53-62. PubMed ID: 30389594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.
    Le CH; Benage LG; Specht KS; Li Puma LC; Mulligan CM; Heuberger AL; Prenni JE; Claypool SM; Chatfield KC; Sparagna GC; Chicco AJ
    J Biol Chem; 2020 Aug; 295(35):12485-12497. PubMed ID: 32665401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac metabolic pathways affected in the mouse model of barth syndrome.
    Huang Y; Powers C; Madala SK; Greis KD; Haffey WD; Towbin JA; Purevjav E; Javadov S; Strauss AW; Khuchua Z
    PLoS One; 2015; 10(6):e0128561. PubMed ID: 26030409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome.
    Acehan D; Vaz F; Houtkooper RH; James J; Moore V; Tokunaga C; Kulik W; Wansapura J; Toth MJ; Strauss A; Khuchua Z
    J Biol Chem; 2011 Jan; 286(2):899-908. PubMed ID: 21068380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tafazzin Mutation Affecting Cardiolipin Leads to Increased Mitochondrial Superoxide Anions and Mitophagy Inhibition in Barth Syndrome.
    Petit PX; Ardilla-Osorio H; Penalvia L; Rainey NE
    Cells; 2020 Oct; 9(10):. PubMed ID: 33096711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
    Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX
    Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.
    Zegallai HM; Hatch GM
    Mol Cell Biochem; 2021 Mar; 476(3):1605-1629. PubMed ID: 33415565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiolipin metabolism and the role it plays in heart failure and mitochondrial supercomplex formation.
    Mejia EM; Cole LK; Hatch GM
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):98-106. PubMed ID: 24801725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-targeted antioxidant prevents cardiac dysfunction induced by tafazzin gene knockdown in cardiac myocytes.
    He Q; Harris N; Ren J; Han X
    Oxid Med Cell Longev; 2014; 2014():654198. PubMed ID: 25247053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
    Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of mitochondrial oxodicarboxylate carrier (ODC1) preserves oxidative phosphorylation in a yeast model of Barth syndrome.
    de Taffin de Tilques M; Tribouillard-Tanvier D; Tétaud E; Testet E; di Rago JP; Lasserre JP
    Dis Model Mech; 2017 Apr; 10(4):439-450. PubMed ID: 28188263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.
    Ikon N; Ryan RO
    Lipids; 2017 Feb; 52(2):99-108. PubMed ID: 28070695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Function of Tafazzin, a Mitochondrial Phospholipid-Lysophospholipid Acyltransferase.
    Schlame M; Xu Y
    J Mol Biol; 2020 Aug; 432(18):5043-5051. PubMed ID: 32234310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiolipin deficiency in Barth syndrome is not associated with increased superoxide/H
    Goncalves RLS; Schlame M; Bartelt A; Brand MD; Hotamışlıgil GS
    FEBS Lett; 2021 Feb; 595(3):415-432. PubMed ID: 33112430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome.
    Russo S; De Rasmo D; Rossi R; Signorile A; Lobasso S
    Sci Rep; 2024 Jun; 14(1):13655. PubMed ID: 38871974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
    Hsu P; Liu X; Zhang J; Wang HG; Ye JM; Shi Y
    Autophagy; 2015 Apr; 11(4):643-52. PubMed ID: 25919711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiolipin metabolism and its causal role in the etiology of the inherited cardiomyopathy Barth syndrome.
    Gaspard GJ; McMaster CR
    Chem Phys Lipids; 2015 Dec; 193():1-10. PubMed ID: 26415690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients.
    McKenzie M; Lazarou M; Thorburn DR; Ryan MT
    J Mol Biol; 2006 Aug; 361(3):462-9. PubMed ID: 16857210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.
    Kimura T; Kimura AK; Ren M; Berno B; Xu Y; Schlame M; Epand RM
    Biochemistry; 2018 Apr; 57(14):2162-2175. PubMed ID: 29557170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome.
    Kiebish MA; Yang K; Liu X; Mancuso DJ; Guan S; Zhao Z; Sims HF; Cerqua R; Cade WT; Han X; Gross RW
    J Lipid Res; 2013 May; 54(5):1312-25. PubMed ID: 23410936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.